Delivery Order SPE2DB22D2211-SPE2DB25FSALV

Award Date 7/9/25
Potential Completion Date 7/10/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,568,508,331 units of the medication eletriptan hydrobromide 40 mg tablets. The contract has a ceiling value of $1,242.28 and a period of performance through June 11, 2025. It is a firm-fixed price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,534.76 firm-fixed-price delivery order is for the supply of ELETRIPTAN HBR 20 MG TABLET UD 6S, a prescription medication. The contract has an ultimate completion date of May 29, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,986.69 firm fixed-price delivery order is for the supply of ELETRIPTAN HBR 40 MG TABLET UD 6S, a specialty medication. The contract has an ultimate completion date of September 26, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ELETRIPTAN HBR 20 MG TABLET UD 6S, with a ceiling value of $1,244.57 and a completion date of May 29, 2025. The contract is not set-aside and was awarded on May 28, 2025. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ELETRIPTAN HBR 40 MG TABLET UD 6S, a prescription medication, with an ultimate completion date of June 10, 2025 and a ceiling value of $1,450.63. The contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $2,179.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ELETRIPTAN HBR 40 MG TABLET UD 6S, with an ultimate completion date of August 30, 2022. AmerisourceBergen holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ELETRIPTAN HBR 40 MG TABLET UD 6S. The contract, valued at $1,107.36, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 26, 2025. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This contract is not set aside and is...
This federal contract award, valued at $1,155.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ELETRIPTAN HBR 20 MG TABLET UD 6S, a pharmaceutical product, and has an ultimate completion date of February 6, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,426.71 delivery order contract is for the supply of the medication ELETRIPTAN HBR 20 MG TABLET UD 6S. The contract has an ultimate completion date of October 28, 2024 and a firm fixed price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a $1,093.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the medication eletriptan HBR 20 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FSALV
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ELETRIPTAN HBR 20 MG TABLET UD 6S, with a ceiling value of $1,534.70 and a period of performance through July 10, 2025. The contract is not set aside.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 10/8/25, 10:58 AM